SHPAX vs. SIBPX

Last updated Jun 23, 2026

SHPAX (Saratoga Health & Biotechnology Fund) and SIBPX (Saratoga Investment Quality Bond Portfolio) are both mutual funds - SHPAX is a Health & Biotech Equities fund managed by Saratoga, while SIBPX is a Short-Term Bond fund managed by Saratoga. Over the past 5 years, SHPAX returned 4.70%/yr vs 1.10%/yr for SIBPX. At a 0.09 correlation, their price movements are largely independent. SHPAX charges 2.90%/yr vs 1.54%/yr for SIBPX.

Performance

SHPAX vs. SIBPX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Saratoga Health & Biotechnology Fund (SHPAX) and Saratoga Investment Quality Bond Portfolio (SIBPX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, SHPAX achieves a -0.71% return, which is significantly higher than SIBPX's -0.85% return.

SHPAX

• 1D: -0.94%
• 1M: -1.58%
• YTD: -0.71%
• 6M: -1.86%
• 1Y: 15.99%
• 3Y*: 6.73%
• 5Y*: 4.70%
• 10Y*: 6.52%

SIBPX

• 1D: 0.21%
• 1M: 0.52%
• YTD: -0.85%
• 6M: -0.75%
• 1Y: 2.48%
• 3Y*: 3.05%
• 5Y*: 1.10%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

SHPAX vs. SIBPX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
SHPAX Saratoga Health & Biotechnology Fund	-0.71%	17.43%	0.26%	-0.36%	1.93%	16.71%	3.52%	27.67%	-5.30%	0.49%
SIBPX Saratoga Investment Quality Bond Portfolio	-0.85%	6.50%	0.78%	2.90%	-2.51%	-1.73%	3.34%	3.84%	-0.72%	-0.13%

Correlation

The correlation between SHPAX and SIBPX is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.31
Correlation (3Y) Calculated over the trailing 3-year period	0.24
Correlation (5Y) Calculated over the trailing 5-year period	0.19
Correlation (All Time) Calculated using the full available price history since Jun 12, 2017	0.09

Over the past year, SHPAX and SIBPX have become more correlated (0.31) than their long-term average of 0.09, meaning their price movements have been converging.

Return for Risk

SHPAX vs. SIBPX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SHPAX

SHPAX Risk / Return Rank: 18
SHPAX Sharpe Ratio Rank: 16
SHPAX Sortino Ratio Rank: 17
SHPAX Omega Ratio Rank: 15
SHPAX Calmar Ratio Rank: 24
SHPAX Martin Ratio Rank: 17

SIBPX

SIBPX Risk / Return Rank: 8
SIBPX Sharpe Ratio Rank: 9
SIBPX Sortino Ratio Rank: 8
SIBPX Omega Ratio Rank: 8
SIBPX Calmar Ratio Rank: 8
SIBPX Martin Ratio Rank: 8

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SHPAX vs. SIBPX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Saratoga Health & Biotechnology Fund (SHPAX) and Saratoga Investment Quality Bond Portfolio (SIBPX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	SHPAX	SIBPX	Difference
Sharpe ratio: Return per unit of total volatility	1.07	0.67	+0.40
Sortino ratio: Return per unit of downside risk	1.62	1.00	+0.62
Omega ratio: Gain probability vs. loss probability	1.19	1.12	+0.07
Calmar ratio: Return relative to maximum drawdown	1.67	0.79	+0.89
Martin ratio: Return relative to average drawdown	4.18	2.15	+2.03

SHPAX vs. SIBPX - Sharpe Ratio Comparison

The current SHPAX Sharpe Ratio is 1.07, which is higher than the SIBPX Sharpe Ratio of 0.67. The chart below compares the historical Sharpe Ratios of SHPAX and SIBPX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

SHPAX vs. SIBPX - Drawdown Comparison

The maximum SHPAX drawdown since its inception was -69.50%, which is greater than SIBPX's maximum drawdown of -5.57%. Use the drawdown chart below to compare losses from any high point for SHPAX and SIBPX.

Drawdown Indicators

	SHPAX	SIBPX	Difference
Max Drawdown Largest peak-to-trough decline	-69.50%	-5.57%	-63.93%
Max Drawdown (1Y) Largest decline over 1 year	-9.33%	-3.30%	-6.03%
Max Drawdown (3Y) Largest decline over 3 years	-16.32%	-4.28%	-12.04%
Max Drawdown (5Y) Largest decline over 5 years	-16.32%	-4.74%	-11.58%
Max Drawdown (10Y) Largest decline over 10 years	-28.05%	—	—
Current Drawdown Current decline from peak	-6.59%	-2.18%	-4.41%
Average Drawdown Average peak-to-trough decline	-27.88%	-1.71%	-26.17%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.73%	1.21%	+2.52%

Volatility

SHPAX vs. SIBPX - Volatility Comparison

Saratoga Health & Biotechnology Fund (SHPAX) has a higher volatility of 5.10% compared to Saratoga Investment Quality Bond Portfolio (SIBPX) at 1.25%. This indicates that SHPAX's price experiences larger fluctuations and is considered to be riskier than SIBPX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SHPAX	SIBPX	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.10%	1.25%	+3.85%
Volatility (6M) Calculated over the trailing 6-month period	10.41%	2.77%	+7.64%
Volatility (1Y) Calculated over the trailing 1-year period	14.60%	3.87%	+10.73%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	14.34%	3.39%	+10.95%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	16.62%	2.76%	+13.86%

SHPAX vs. SIBPX - Expense Ratio Comparison

SHPAX has a 2.90% expense ratio, which is higher than SIBPX's 1.54% expense ratio.

Dividends

SHPAX vs. SIBPX - Dividend Comparison

SHPAX's dividend yield for the trailing twelve months is around 3.69%, more than SIBPX's 2.04% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
SHPAX Saratoga Health & Biotechnology Fund	3.69%	3.66%	1.35%	5.38%	6.34%	3.76%	13.82%	13.24%	22.00%	17.98%	12.52%	10.70%
SIBPX Saratoga Investment Quality Bond Portfolio	2.04%	2.24%	2.31%	1.54%	0.14%	1.39%	0.58%	0.99%	1.21%	1.03%	0.00%	0.00%

Frequently Asked Questions

Can I hold both SHPAX and SIBPX in my portfolio?

SHPAX and SIBPX have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, SHPAX or SIBPX?

SHPAX has higher volatility (5.10%) compared to SIBPX (1.25%). In terms of maximum drawdown, SHPAX dropped -69.50% vs SIBPX's -5.57%.

Which has better risk-adjusted returns?

SHPAX currently has the higher Sharpe Ratio (1.07 vs 0.67), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.